世界の抗糖尿病薬市場予測2023-2029:1型糖尿病、2型糖尿病、その他

【英語タイトル】Antidiabetics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5677)・商品コード:MMG23JU5677
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:73
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の抗糖尿病薬市場規模と予測を収録しています。・世界の抗糖尿病薬市場:売上、2018年-2023年、2024年-2029年
・世界の抗糖尿病薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗糖尿病薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「1型糖尿病」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗糖尿病薬のグローバル主要企業は、Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、抗糖尿病薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗糖尿病薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場:タイプ別市場シェア、2022年
・1型糖尿病、2型糖尿病、その他

世界の抗糖尿病薬市場:用途別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場:用途別市場シェア、2022年
・病院、診療所、家庭、その他

世界の抗糖尿病薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗糖尿病薬のグローバル売上、2018年-2023年
・主要企業における抗糖尿病薬のグローバル売上シェア、2022年
・主要企業における抗糖尿病薬のグローバル販売量、2018年-2023年
・主要企業における抗糖尿病薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizer

*************************************************************

・調査・分析レポートの概要
抗糖尿病薬市場の定義
市場セグメント
世界の抗糖尿病薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗糖尿病薬市場規模
世界の抗糖尿病薬市場規模:2022年 VS 2029年
世界の抗糖尿病薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗糖尿病薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗糖尿病薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:1型糖尿病、2型糖尿病、その他
抗糖尿病薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、家庭、その他
抗糖尿病薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗糖尿病薬市場規模 2022年と2029年
地域別抗糖尿病薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizer
...

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
This report aims to provide a comprehensive presentation of the global market for Antidiabetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetics. This report contains market size and forecasts of Antidiabetics in global, including the following market information:
Global Antidiabetics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antidiabetics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Antidiabetics companies in 2022 (%)
The global Antidiabetics market was valued at US$ 59860 million in 2022 and is projected to reach US$ 86650 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antidiabetics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidiabetics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, by Type, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Other
Global Antidiabetics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Antidiabetics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidiabetics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antidiabetics revenues share in global market, 2022 (%)
Key companies Antidiabetics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Antidiabetics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antidiabetics, market overview.
Chapter 2: Global Antidiabetics market size in revenue and volume.
Chapter 3: Detailed analysis of Antidiabetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antidiabetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antidiabetics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antidiabetics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antidiabetics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antidiabetics Overall Market Size
2.1 Global Antidiabetics Market Size: 2022 VS 2029
2.2 Global Antidiabetics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antidiabetics Sales: 2018-2029
3 Company Landscape
3.1 Top Antidiabetics Players in Global Market
3.2 Top Global Antidiabetics Companies Ranked by Revenue
3.3 Global Antidiabetics Revenue by Companies
3.4 Global Antidiabetics Sales by Companies
3.5 Global Antidiabetics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antidiabetics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antidiabetics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antidiabetics Players in Global Market
3.8.1 List of Global Tier 1 Antidiabetics Companies
3.8.2 List of Global Tier 2 and Tier 3 Antidiabetics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antidiabetics Market Size Markets, 2022 & 2029
4.1.2 Type 1 Diabetes
4.1.3 Type 2 Diabetes
4.1.4 Other
4.2 By Type – Global Antidiabetics Revenue & Forecasts
4.2.1 By Type – Global Antidiabetics Revenue, 2018-2023
4.2.2 By Type – Global Antidiabetics Revenue, 2024-2029
4.2.3 By Type – Global Antidiabetics Revenue Market Share, 2018-2029
4.3 By Type – Global Antidiabetics Sales & Forecasts
4.3.1 By Type – Global Antidiabetics Sales, 2018-2023
4.3.2 By Type – Global Antidiabetics Sales, 2024-2029
4.3.3 By Type – Global Antidiabetics Sales Market Share, 2018-2029
4.4 By Type – Global Antidiabetics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antidiabetics Market Size, 2022 & 2029
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application – Global Antidiabetics Revenue & Forecasts
5.2.1 By Application – Global Antidiabetics Revenue, 2018-2023
5.2.2 By Application – Global Antidiabetics Revenue, 2024-2029
5.2.3 By Application – Global Antidiabetics Revenue Market Share, 2018-2029
5.3 By Application – Global Antidiabetics Sales & Forecasts
5.3.1 By Application – Global Antidiabetics Sales, 2018-2023
5.3.2 By Application – Global Antidiabetics Sales, 2024-2029
5.3.3 By Application – Global Antidiabetics Sales Market Share, 2018-2029
5.4 By Application – Global Antidiabetics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antidiabetics Market Size, 2022 & 2029
6.2 By Region – Global Antidiabetics Revenue & Forecasts
6.2.1 By Region – Global Antidiabetics Revenue, 2018-2023
6.2.2 By Region – Global Antidiabetics Revenue, 2024-2029
6.2.3 By Region – Global Antidiabetics Revenue Market Share, 2018-2029
6.3 By Region – Global Antidiabetics Sales & Forecasts
6.3.1 By Region – Global Antidiabetics Sales, 2018-2023
6.3.2 By Region – Global Antidiabetics Sales, 2024-2029
6.3.3 By Region – Global Antidiabetics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antidiabetics Revenue, 2018-2029
6.4.2 By Country – North America Antidiabetics Sales, 2018-2029
6.4.3 US Antidiabetics Market Size, 2018-2029
6.4.4 Canada Antidiabetics Market Size, 2018-2029
6.4.5 Mexico Antidiabetics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antidiabetics Revenue, 2018-2029
6.5.2 By Country – Europe Antidiabetics Sales, 2018-2029
6.5.3 Germany Antidiabetics Market Size, 2018-2029
6.5.4 France Antidiabetics Market Size, 2018-2029
6.5.5 U.K. Antidiabetics Market Size, 2018-2029
6.5.6 Italy Antidiabetics Market Size, 2018-2029
6.5.7 Russia Antidiabetics Market Size, 2018-2029
6.5.8 Nordic Countries Antidiabetics Market Size, 2018-2029
6.5.9 Benelux Antidiabetics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antidiabetics Revenue, 2018-2029
6.6.2 By Region – Asia Antidiabetics Sales, 2018-2029
6.6.3 China Antidiabetics Market Size, 2018-2029
6.6.4 Japan Antidiabetics Market Size, 2018-2029
6.6.5 South Korea Antidiabetics Market Size, 2018-2029
6.6.6 Southeast Asia Antidiabetics Market Size, 2018-2029
6.6.7 India Antidiabetics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antidiabetics Revenue, 2018-2029
6.7.2 By Country – South America Antidiabetics Sales, 2018-2029
6.7.3 Brazil Antidiabetics Market Size, 2018-2029
6.7.4 Argentina Antidiabetics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antidiabetics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antidiabetics Sales, 2018-2029
6.8.3 Turkey Antidiabetics Market Size, 2018-2029
6.8.4 Israel Antidiabetics Market Size, 2018-2029
6.8.5 Saudi Arabia Antidiabetics Market Size, 2018-2029
6.8.6 UAE Antidiabetics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Antidiabetics Major Product Offerings
7.1.4 Sanofi-Aventis Antidiabetics Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi-Aventis Key News & Latest Developments
7.2 Takeda Pharmaceuticals
7.2.1 Takeda Pharmaceuticals Company Summary
7.2.2 Takeda Pharmaceuticals Business Overview
7.2.3 Takeda Pharmaceuticals Antidiabetics Major Product Offerings
7.2.4 Takeda Pharmaceuticals Antidiabetics Sales and Revenue in Global (2018-2023)
7.2.5 Takeda Pharmaceuticals Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Antidiabetics Major Product Offerings
7.3.4 Eli Lilly Antidiabetics Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Oramed Pharmaceuticals
7.4.1 Oramed Pharmaceuticals Company Summary
7.4.2 Oramed Pharmaceuticals Business Overview
7.4.3 Oramed Pharmaceuticals Antidiabetics Major Product Offerings
7.4.4 Oramed Pharmaceuticals Antidiabetics Sales and Revenue in Global (2018-2023)
7.4.5 Oramed Pharmaceuticals Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Antidiabetics Major Product Offerings
7.5.4 Boehringer Ingelheim Antidiabetics Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Company Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Antidiabetics Major Product Offerings
7.6.4 Merck & Co. Inc. Antidiabetics Sales and Revenue in Global (2018-2023)
7.6.5 Merck & Co. Inc. Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Antidiabetics Major Product Offerings
7.7.4 Novo Nordisk Antidiabetics Sales and Revenue in Global (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Antidiabetics Major Product Offerings
7.8.4 Bristol-Myers Squibb Antidiabetics Sales and Revenue in Global (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Halozyme Therapeutics
7.9.1 Halozyme Therapeutics Company Summary
7.9.2 Halozyme Therapeutics Business Overview
7.9.3 Halozyme Therapeutics Antidiabetics Major Product Offerings
7.9.4 Halozyme Therapeutics Antidiabetics Sales and Revenue in Global (2018-2023)
7.9.5 Halozyme Therapeutics Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Antidiabetics Major Product Offerings
7.10.4 Pfizer Antidiabetics Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
8 Global Antidiabetics Production Capacity, Analysis
8.1 Global Antidiabetics Production Capacity, 2018-2029
8.2 Antidiabetics Production Capacity of Key Manufacturers in Global Market
8.3 Global Antidiabetics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antidiabetics Supply Chain Analysis
10.1 Antidiabetics Industry Value Chain
10.2 Antidiabetics Upstream Market
10.3 Antidiabetics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antidiabetics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界の抗糖尿病薬市場予測2023-2029:1型糖尿病、2型糖尿病、その他] (コード:MMG23JU5677)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗糖尿病薬市場予測2023-2029:1型糖尿病、2型糖尿病、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆